Last reviewed · How we verify
NCT06754189
Safety and Performance of UCon Patch Electrode
NA trial testing Time Limited stimulation in Urinary Incontinence in 180 participants. Currently enrolling.
20 March 2028
Quick facts
| Lead sponsor | InnoCon Medical |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 180 |
| Start date | 20 March 2025 |
| Primary completion | 20 March 2028 |
| Estimated completion | 20 March 2028 |
| Sites | 3 locations across Denmark |
Drugs / interventions tested
- Time Limited stimulation
- Sham stimulation
Conditions studied
- Urinary Incontinence — all drugs for Urinary Incontinence →
- Urinary Incontinence, Urge — all drugs for Urinary Incontinence, Urge →
- Nocturia — all drugs for Nocturia →
- Urinary Frequency More Than Once at Night — all drugs for Urinary Frequency More Than Once at Night →
Sponsor
InnoCon Medical
Who can join
18 and older, any sex, with Urinary Incontinence or Urinary Incontinence, Urge. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
UCon is a medical device for treating the symptoms of overactive bladder (OAB) and bowel dysfunction (BD). It electrically stimulates the DGN through the skin to obtain modulated behavior of the bladder/bowel musculature e.g., suppressing undesired bladder/bowel activity to relieve the symptoms of the patient. This pivotal clinical investigation is designed as a stratified-randomized, single-blinded, controlled, confirmatory, prospective, multicenter clinical investigation.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06754189
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Urinary Incontinence
Currently open trials in the same condition.
- NCT07430865 — The RECOVER Study - Postpartum Recovery of Pelvic Floor Structures and the Impact of Early Rehabilitation · NA · recruiting
- NCT07105150 — Efficacy of a Video-Based Educational Program on Female Urinary Incontinence · NA · recruiting
- NCT07426861 — Pre-Operative Nurse-Led Education With Direct Physiotherapy Referral to Reduce Post-Prostatectomy Incontinence · NA · recruiting
- NCT07413692 — BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Urinary Incontinence in Postpartum and E · NA · recruiting
- NCT07413705 — BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Sexual Function Among Perimenopausal and · NA · recruiting
Other InnoCon Medical trials
Trials by the same sponsor.
- NCT06091566 — Safety and Performance of UCon Bar Electrode for the Treatment of Overactive Bladder (OAB) and Bowel Dysfunction (BD) · NA · recruiting
- NCT05874375 — UCon Treatment of Overactive Bladder (OAB) in Males · NA · recruiting
- NCT05864807 — UCon Treatment of the Symptoms of Faecal Incontinence (FI) · NA · completed
- NCT05368246 — Safety and Performance of UCon for the Treatment of the Symptoms of Overactive Bladder (OAB) / Bowel Dysfunction (BD) · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06754189 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by InnoCon Medical
- Last refreshed: 27 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06754189.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing